Ingevity Corporation
Ingevity Corporation (NGVT) Revenue
Annual & quarterly revenue history · segment & region breakdown
NGVT · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsIngevity Corporation trailing twelve-month (TTM) revenue is $1.21B, a decrease of 16.98% year-over-year from $1.17B in FY2025.
Revenue trend
2025 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $1.17B | -$0.24B | -16.98% |
| 2024-12-31 | $1.41B | -$0.29B | -16.88% |
| 2023-12-31 | $1.69B | +$0.02B | +1.43% |
| 2022-12-31 | $1.67B | +$0.28B | +19.89% |
| 2021-12-31 | $1.39B | +$0.18B | +14.42% |
| 2020-12-31 | $1.22B | -$0.08B | -5.94% |
| 2019-12-31 | $1.29B | +$0.16B | +14.05% |
| 2018-12-31 | $1.13B | +$0.16B | +16.58% |
| 2017-12-31 | $0.97B | +$0.06B | +7.06% |
| 2016-12-31 | $0.91B | -$0.06B | -6.17% |
Compare revenue vs peers
Chemicals - SpecialtyCompare NGVT revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Ingevity Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Ingevity Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Ingevity Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
NGVT revenue · 5 questionsNGVT's trailing twelve-month (TTM) revenue is $1.21B. That is a decrease of 16.98% year-over-year from $1.17B in FY2025.
▸ Source: FMP · Ingevity Corporation SEC filings · GAAP · Ingevity Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026